Literature DB >> 9627086

Effects of methylenechloride-soluble fraction of Japanese angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in group-housed and socially isolated mice.

K Matsumoto1, S Kohno, K Ojima, Y Tezuka, S Kadota, H Watanabe.   

Abstract

We previously showed that the extract of Japanese angelica root (JAR-E) reversed the decrease in pentobarbital (PB) sleep induced by isolation stress and yohimbine and methoxamine, stimulants of central noradrenergic systems, in mice. Here, we tested the effects of several fractions from JAR-E and ligustilide and butylidenephthalide, phthalide components of JAR-E, on PB sleep in isolated mice to elucidate the mechanism of the action of JAR-E. Methanol-soluble (Met-S) and -insoluble (Met-IS) fractions were obtained from JAR-E. Methylenechloride-soluble (MC-S) and -insoluble fractions (MC-IS) were prepared from Met-S. MC-S (11.4-76 mg/kg, p.o.) reversed the isolation stress-induced decrease in PB sleep, but neither Met-IS (0.8-2.4 g/kg, p.o.) nor MC-IS (0.7-2 g/kg, p.o.) had the same effect. The i.p. administration of MC-S exhibited a similar activity to that observed after the p.o. administration of the same fraction. Ligustilide (5-20 mg/kg, i.p.) and butylidenephthalide (10-30 mg/kg, i.p.) reversed PB sleep decrease in isolated mice. Both components (20 mg/kg, i.p.) attenuated the suppressive effects of yohimbine (30 nmol, i.c.v.), methoxamine (200 nmol, i.c.v.) and a benzodiazepine inverse agonist FG7142 (10 mg/kg, i.p.) on PB sleep in group-housed mice. These results suggest the contribution of ligustilide and butylidenephthalide to the effect of JAR-E on PB sleep in isolated mice, and implicate central noradrenergic and/or GABA(A) systems in the effects of these components.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627086     DOI: 10.1016/s0024-3205(98)00182-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1.

Authors:  Birgit M Dietz; Dongting Liu; Ghenet K Hagos; Ping Yao; Andreas Schinkovitz; Samuel M Pro; Shixin Deng; Norman R Farnsworth; Guido F Pauli; Richard B van Breemen; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2008-09-23       Impact factor: 3.739

3.  Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells.

Authors:  Yan Yu; Jun-Rong Du; Chen-Yuan Wang; Zhong-Ming Qian
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972

4.  Alleviation of Morphine Withdrawal Signs but Not Tolerance by the Essential Oil of Kelussia odoratissima Mozaff.

Authors:  Mohammed Rabbani; Seyed Ebrahim Sajjadi; Azadeh Izadi
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-05       Impact factor: 2.629

5.  Angelica gigas ameliorate depression-like symptoms in rats following chronic corticosterone injection.

Authors:  Bombi Lee; Bongjun Sur; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  BMC Complement Altern Med       Date:  2015-07-03       Impact factor: 3.659

6.  Potentiation of decursinol angelate on pentobarbital-induced sleeping behaviors via the activation of GABAA-ergic systems in rodents.

Authors:  Jae Hoon Woo; Tae-Woo Ha; Jae-Seon Kang; Jin Tae Hong; Ki-Wan Oh
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

Review 7.  Sleep-Aids Derived from Natural Products.

Authors:  Zhenzhen Hu; Seikwan Oh; Tae-Woo Ha; Jin-Tae Hong; Ki-Wan Oh
Journal:  Biomol Ther (Seoul)       Date:  2018-07-01       Impact factor: 4.634

Review 8.  Advances in the chemical analysis and biological activities of chuanxiong.

Authors:  Weixia Li; Yuping Tang; Yanyan Chen; Jin-Ao Duan
Journal:  Molecules       Date:  2012-09-06       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.